liter (p < 0.05). The change in serum sodium concentration correlated with plasma renin activity and aldosterone (r = -0.77, -0.88, respectively, both p < O.Ol), but not with norepinephrine or atria1 natriuretic factor. When sinus rhythm was restored, 14 dogs were observed for 48 to 72 h and 8 dogs were followed up for another 4 weeks after cessation of pacing. Recovery from heart failure was characterized by a return of all neuroendocrine variables, serum sodium and urea levels to control values by 48 to 72 h.
The unique time profile of atria1 natriuretic factor during the developing heart failure suggests that the circulating level of this hormone may not be sufficient to maintain circulatory homeostasis in advanced heart failure. The strong negative correlations among the change in serum sodium and plasma renin and aldosterone support the hypothesis proposed by previous clinical studies that hyponatremia in congestive heart failure is in part mediated by the activation of the renin-angiotensin system. (J Am Co11 Cardiol1989; 13:173-9) and arginine vasopressin in patients with heart failure. Increased plasma norepinephrine concentration and renin activity have been associated with poor clinical outcome (4.5). Furthermore, the development of hyponatremia is thought to reflect the degree of activation of the reninangiotensin system and to be associated with a poor prognosis (5). Recent interest in atrial natriuretic fxtor. a group of peptides with potent diuretic and natriuretic properties (6-XI, inhibitory effects on blood pressure (6,9,10) and the renin-angiotensin system (91, has led to speculation that atrial natriuretic factor may also play a pathogenetic role in heart failure. Several studies (1 I, 12 ) have now demonstrated increased plasma immunoreactive atrial natriuretic factor concentrations in patients with heart failure.
Most clinical studies to date have involved single measurements over time. measured at baseline and at the end of the 8 week observation period demonstrated no significant changes over the 8 week period. In the paced group, in contrast to the sham group, both serum urea and creatinine increased significantly at severe heart failure. Furthermore, the level of serum sodium declined significantly and the level of potassium increased. With cessation of pacing, all variables returned to control values rapidly. Neuroendocrine measurements ( Fig. 1 and 2 ). In the sham-operated group (Fig. l) , the control values for plasma norepinephrine, plasma renin activity, aldosterone and atrial natriuretic factor were 270 ? 34 pg/ml, 1.7 lr 0.5 &ml per h, 1-1 L LL~ i 43 p&iii and i67 * 36 pgimi, respectlveiy. As expected, no significant change from control over the 8 week period was evident for any of the neuroendocrinc measurcments, attesting to the stability of the experimental model.
In the paced group (Fig. 2) , the control values for the neuroendocrine measurements were comparable with those of the sham group (p = NS). With the initiation of pacing. there was a rapid increase of plasma norepinephrine from the control value of 293 + I5 to 610 ? 79 pg/ml (p < 0.05) by the 1st week; thereafter, it continued to increase, reaching 1,066 i 99 pg/ml (p < 0.01) at severe heart failure ( Fig. 2A) . With resumption of sinus rhythm, the level of plasma norepinephrine declined to 550 + 85 pgiml 524 h (p < 0.01, compared with the value at the time of severe heart failure), returned to the control value by the 1st week and declined slightly more by week 4 to 199 -C 13 pgiml. With regard to plasma renin activity (Fig. 2B) , with rapid pacing, there was a progressive ml per h (p < 0.05) at severe heart failure. When sinus rhythm was restored, plasma renin declined to 2.0 2 0.7 ngi ml per h at 24 h and remained slightly lower than the control value for the subsequent 4 weeks. During the 48 to 72 h after cessation of pacing, there was a significant correlation between the decline in plasma renin and the decrease in body Figure 2 . The control value was 243 ? 76 pg/ml. In contrast to the pattern observed for the other neuroendocrine variables, plasma atria1 natriuretic factor peaked by the 2nd week at 718 -t 223 pglml (p < O.Ol), remained elevated at the end of the 2nd week and started to decline by the 3rd week, eventually reaching 522 + 53 pg/ml at the time of severe heart failure. When sinus rhythm was restored, the ievei further deciined and returned to controi value between 72 h and 1 week and remained low throughout the duration of the recovery period.
Plasma immunoreactive atria1 natriuretic factor values for the paced group are shown in
Relations among the neuroendocrine variables. At the time of severe heart failure, there was a modest correlation between plasma renin activity and norepinephrine (r = 0.62, p < 0.05). As expected, the change in aldosterone paralleled that of plasma renin activity. At severe heart failure, both the absolute values and the percent increase from control for aldosterone correlated strongly with those of renin (r = 0.74, p < 0.05; r = 0.83, p < 0.01, respectively). There were no correlations between these neuroendocrine variables and atria1 natriuretic factor at any time.
Relations among serum sodium, renal function and neuroendocrine variables. To relate the changes in serum electrolytes and renal function with the neuroendocrine changes, regression analysis was performed on serum sodium, potassium, urea, creatinine and all the neuroendocrine variables. *r rL_ r:___ _I ^^..^ -_ I-__-rI?_:,..__ ______ __11.._ ____,_&_?I AL me llrnt: UI seve1-e 11Gi1-1 lalluI-c, Y~Iulll bOUlUIIl ulIl~laLtu inversely with plasma renin activity and aldosterone (r = -0.76, p < 0.01; r = -0.89, p < 0.01, respectively). Furthermore, the percent change in serum sodium between control and severe heart failure also correlated inversely with those of renin and aldosterone (r = -0.77, p < 0.01; r = -0.76, p < 0.01, respectively). Serum sodium, however, did not correlate with either urea or creatinine (r = 0.37, r = 0.49). No correlations were seen among serum sodium, renin activity and aldosterone at baseline or at any time during recovery, and no correlations were observed between serum sodium or potassium, plasma norepinephrine and atria1 natriuretic factor at any time during the study.
Discussion
This study provides three novel observations that provide insight into the model of pacing-induced heart failure. 1) There is a decrease in serum sodium that may in part be NEUROENDOCRINE VARli\HLES IN EXPERIMENTAL HEART FAILURE related to activation of the renin-angiotensin system. 2) The temporal sequence of the release of atria1 natriuretic factor in heart failure has been defined, related to other neuroendocrine variables and found to have a unique and distinct profile. 3) Recovery from advanced heart failure occurs within 48 to 72 h after ressatinn nf nxim 2nd is asso&ted __"--_._. _ __ r-_~"~ --.-with a striking reversal of these neuroendocrine abnormalities. Serum electrolytes and indexes of renal function. The increase in levels of serum potassium, urea and creatinine at severe heart failure likely reflects compromised renal function due to a decrease in renal perfusion. Likewise, the rapid decrease in potassium, urea and creatinine levels coincided with the hemodynamic recovery suggesting an improvement in renai perfusion. The decrease in serum sodium at advanced heart failure in the presence of an increase in body weight and edema formation suggests an impairment in free water clearance. This experimental observation provides support for previous observations of hyponatremia in patients with heart failure (5). The magnitude of the decrease in serum sodium observed in the current study is modest when compared with the striking degree of hyponatremia reported in clinical studies. This discrepancy may in part be related to two factors. First. normal serum sodium in dogs from our laboratory (range 144 to 152 mmoliliter) is higher than that observed in humans (range 135 to 147 mmoliliter). Second, the influence of sodium restriction and intensive diuretic therapy in the clinical studies may have partially accounted for low serum sodium levels.
A lm~ serum sodiutrt le\,el has been proposed (5) NS N marker of CM uqfn~wrrhle prognosis in patients with sel'ere hecrrijiliiure. it is thought that the hyponatremia reiiects an activation of the renin-angiotensin system (5,lS). Similar observations have not been reported in any experimental heart failure model. The mechanisms by which the activation of the renin-angiotensin system leads to hyponatremia are probably multifactorial. First, angiotensin II may reduce renal blood flow (1% leading to intrarenal vasoconstriction. It has been proposed that a selective reduction in renal inner medullary blood flow may enhance countercurrent exchange, thereby limiting the extent of urea retention and also increasing osmolality in the inner medulla inhibiting free water excretion (20). Second, angiotensin II is known to stimulate the thirst center (21). In this regard, it should be noted that although a systematic quantification of water consumption was not made in our study, an adequate supply of water was always ensured. Third, angiotensin also stimulates the production of arginine vasopressin (22). It is cnm-e;\rahle that thece fQrtnro mo,r rnntr;h,,to tn 3 rl~,-rrxc~ ~"~'~~l I LIlllr LLlUL Illrob lUII"l a ','UJ b",,C, ,VUIb L" u Uk,bLbLIJb in free water clearance, thus leading to a decrease in serum sodium.
Plasma renin activity and aldosterone. The parallel increase in renin and aldosterone was gradual, the most rapid increase occurring between the 2nd week and severe heart failure. This steep increase at the time of severe heart failure might be explained by the progressive increase in plasma norepinephrine which, by producing vasoconstriction in the renal vascular bed, further stimulated the release of renin. Indeed, a positive correlation between plasma norepinephrine and renin levels at severe heart failure was demonstrated in this study. The positive correlation between maximal weight loss and decline in renin levels (both occurring in the 48 to 72 h period after cessation of pacing) supports the concept that the decreases in renin and aldosterone were operative in the spontaneous diuresis. The observation that body weight at 48 to 72 h after cessation of pacing (20.7 t 0.7 kg) was significantly less than the control value (22.0 t 0.5 kg) after major spontaneous diuresis suggests that there is i0ss ot^ iean body mass during the deveiopment of heart failure. Finally, the decrease, rather than the increase in plasma atrial natriuretic factor at recovery suggests that the spontaneous diuresis was not mediated by atrial natriuretic factor.
Plasma norepinephrine. Plasma norepinephrine increased significantly after 1 week of pacing and increased progressively to peak at severe heart failure. This pattern likely reflects the progressive hemodynamic deterioration characterizing advancing heart failure. A modest correlation between plasma norepinephrine and the degree of hemodynamic derangement has been demonstrated in patients with heart failure (3). The rapid decline of plasma norepinephrine level at recovery was likely associated with the dramatic clinical and hemodynamic improvement observed after cessation of pacing (17).
Atria1 natriuretic factor. The changes in atria1 natriuretic factor foiiow a time profiie distinct from that of the other neuroendocrine variables. Plasma atria1 natriuretic factor increases and peaks early in the development of heart failure. declines and then reaches a plateau as severe heart failure develops. A similar time profile of the response of atrial natriuretic factor has also been shown in the myopathic Syrian hamster (23). Although the pathogenic role of atria1 natriuretic factor in heart failure remains to be defined, one may formulate the following hypothetical model on the basis of current observations. In the early stage of heart failure. increased atrial pressures result in the release of atrial natriuretic factor, which modulates the effects of the sympathetic nervous system and the renin-angiotensin system. In advanced heart failure, the effects of the vasoconstrictor forces become dominant and exceed the ability of atrial natriuretic factor to modulate these forces. hecwr fuilure. Atrial storage of the hormone may be exhausted as a result of long-term stimulation. In this regard, we have shown previously that the natriuretic activity from the right atrium of dogs in the paced group is significantly less than that from control dogs (14). Reduced natriuretic activity has also been shown in atria1 extracts from other models of heart failure (24-26). These bioassay observations from the latter models are supported by studies on similar _firlDlQ oL.nr*,;..n rh411,.'vl ;mm,lnnro",4rro Qh&l notr;llmt;P LII"Ub,J J'I"Wlll~ I LUULCU lllllllUll"l LLICCI" L. ac1 ,a, 11ac, IUIbLLk factor content in the atria1 tissue (27-29). Indeed, ultrastructural changes in the atria1 myocytes have suggested extreme stimulation of the secretory apparatus for the hormone (30). Such intense stimulation may conceivably result in a decrease in atria1 stores of the hormone. Furthermore, reduced left atria1 compliance and receptor morphology (31) , as well as decreased rate of firing of these receptors to stretch sti_mu!us (32) , have been observed in dogs with chronic heart failure. This may explain the attenuated atrial-diuretic reflex previously observed in dogs (33) . These observations therefore suggest that reduced atria1 sensitivity to stretch stimulus may be another mechanism for the failure of plasma atria1 natriuretic factor to increase further in severe heart failure. Possible limitations. This study did not address the possibility that the target organs may be resistant to the effects of atria1 natriuretic factor in severe heart failure. Indeed, attenuated renal response to the exogenous administration of atria1 natriuretic factor has been observed in experimental heart failure models (34) . It is also important to note that in this study, assays of atria1 natriuretic factor were performed on unextracted plasma. This approach would yield higher values than those obtained by the extracted method. However, given that a linear relation exists between atria1 natriuretic factor concentrations assayed by the direct versus the extracted method over the range of values reported in this study (35, 36) , a similar time profile for the change in atria1 natriuretic factor would be expected had the extracted method been employed. Furthermore, the plasma concentrations reported in this study might represent a combination of prohormone and active hormone. Although previous studies (35, 36) employing high pressure liquid chromatography indicate that 99-126 atria1 natriuretic factor (the active hormone) is the major moiecuiar species in the peripherai plasma, the exact proportion of each molecular species cannot be ascertained from the current study. Finally, we cannot exclude the possibility that other unmeasured endogenous vasodilating hormones such as prostaglandins and kinins may also be important in the modulation of serum sodium and maintainence of circulatory homeostasis (37) .
Conclusions. Chronic pacing-induced heart failure in dogs is accompanied by an activation of several neuroendocrine variables. Recovery from heart failure is feasible in this model and is accompanied by a rapid return of these variables to control values. The unique time profile for changes in plasma atria1 natriuretic factor during the development of heart failure suggests that, although there is increased release of this hormone at severe heart failure, it is not sufficient to modulate circulatory homeostasis. 
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